These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10365721)

  • 1. Effect of pharmaceutical services on adherence to criteria-for-use guidelines in the operating room.
    Higgins B; Patel P; Bach DS
    Am J Health Syst Pharm; 1999 May; 56(10):977-82. PubMed ID: 10365721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.
    Rhoney DH; Murry KR
    J Intensive Care Med; 2003; 18(3):139-45. PubMed ID: 14984632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of sedative, analgesic, and neuromuscular blocking agent guidelines in a medical intensive care unit: physician and nurse adherence.
    Bair N; Bobek MB; Hoffman-Hogg L; Mion LC; Slomka J; Arroliga AC
    Crit Care Med; 2000 Mar; 28(3):707-13. PubMed ID: 10752819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blockade, reversal agent use, and operating room time: retrospective analysis of US inpatient surgeries.
    Zhang B; Hepner DL; Tran MH; Friedman M; Korn JR; Menzin J
    Curr Med Res Opin; 2009 Apr; 25(4):943-50. PubMed ID: 19257799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children.
    Johnson PN; Miller J; Gormley AK
    Pharmacotherapy; 2011 Jun; 31(6):609-20. PubMed ID: 21923445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sedative use in patients receiving neuromuscular blocking agents from a helicopter flight team.
    Frakes MA; Lord WR
    Air Med J; 2006; 25(4):173-5. PubMed ID: 16818168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacoeconomic analysis of neuromuscular blocking agents in the operating room.
    Loughlin KA; Weingarten CM; Nagelhout J; Stevenson JG
    Pharmacotherapy; 1996; 16(5):942-50. PubMed ID: 8888091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of algorithms for treating patients in the intensive care unit.
    Maloney M; Camamo J; Crinnion C; Johnson SB; Erstad BL
    Am J Health Syst Pharm; 1997 Aug; 54(16):1841-5. PubMed ID: 9269522
    [No Abstract]   [Full Text] [Related]  

  • 9. National survey on the use of sedatives and neuromuscular blocking agents in the pediatric intensive care unit.
    Rhoney DH; Murry KR
    Pediatr Crit Care Med; 2002 Apr; 3(2):129-133. PubMed ID: 12780981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a policy for patients receiving neuromuscular blocking agents.
    Earl G; McMahon MB; Bartley M; Mancini W; Becker S
    J Trauma Nurs; 1997; 4(3):76-81. PubMed ID: 9407819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prescribing guidelines on the use of neuromuscular blocking agents.
    Gora-Harper ML; Hessel E; Shadick D
    Am J Health Syst Pharm; 1995 Sep; 52(17):1900-4. PubMed ID: 8528853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost comparisons of pharmacological strategies in open-heart surgery.
    Reddy P; Song J
    Pharmacoeconomics; 2003; 21(4):249-62. PubMed ID: 12600220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome.
    Arroliga AC; Thompson BT; Ancukiewicz M; Gonzales JP; Guntupalli KK; Park PK; Wiedemann HP; Anzueto A;
    Crit Care Med; 2008 Apr; 36(4):1083-8. PubMed ID: 18401254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost.
    Devlin JW; Holbrook AM; Fuller HD
    Ann Pharmacother; 1997 Jun; 31(6):689-95. PubMed ID: 9184706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients.
    Forni A; Skehan N; Hartman CA; Yogaratnam D; Njoroge M; Schifferdecker C; Lilly CM
    Ann Pharmacother; 2010 Mar; 44(3):432-8. PubMed ID: 20164471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy-Driven Dexmedetomidine Stewardship and Appropriate Use Guidelines in a Community Hospital Setting.
    Schickli MA; Eberwein KA; Short MR; Ratliff PD
    Ann Pharmacother; 2017 Jan; 51(1):27-32. PubMed ID: 27543645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of sedatives, analgesics, and neuromuscular blocking agents in adults receiving extracorporeal membrane oxygenation.
    DeGrado JR; Hohlfelder B; Ritchie BM; Anger KE; Reardon DP; Weinhouse GL
    J Crit Care; 2017 Feb; 37():1-6. PubMed ID: 27610584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.